Michael Ulz

Stock Analyst at Morgan Stanley

(4.56)
# 272
Out of 5,043 analysts
99
Total ratings
56.67%
Success rate
29.59%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Michael Ulz

Viking Therapeutics
Oct 23, 2025
Maintains: Overweight
Price Target: $98$102
Current: $34.42
Upside: +196.34%
Mirum Pharmaceuticals
Oct 16, 2025
Maintains: Overweight
Price Target: $75$81
Current: $70.02
Upside: +15.68%
Ionis Pharmaceuticals
Oct 16, 2025
Maintains: Overweight
Price Target: $86$90
Current: $70.86
Upside: +27.01%
Karyopharm Therapeutics
Oct 9, 2025
Maintains: Outperform
Price Target: $25$21
Current: $6.34
Upside: +231.23%
Alnylam Pharmaceuticals
Oct 6, 2025
Maintains: Equal-Weight
Price Target: $405$475
Current: $463.43
Upside: +2.50%
Silence Therapeutics
May 9, 2025
Maintains: Overweight
Price Target: $45$25
Current: $7.30
Upside: +242.47%
Kyverna Therapeutics
Apr 1, 2025
Maintains: Overweight
Price Target: $40$20
Current: $7.44
Upside: +168.82%
Cabaletta Bio
Apr 1, 2025
Maintains: Overweight
Price Target: $30$22
Current: $2.47
Upside: +790.69%
Aardvark Therapeutics
Mar 10, 2025
Initiates: Overweight
Price Target: $29
Current: $10.70
Upside: +171.03%
Iovance Biotherapeutics
Feb 28, 2025
Maintains: Outperform
Price Target: $24$20
Current: $2.25
Upside: +788.89%
Maintains: Overweight
Price Target: $18$10
Current: $1.38
Upside: +624.64%
Maintains: Overweight
Price Target: $46$96
Current: $53.77
Upside: +78.54%
Maintains: Overweight
Price Target: $48$52
Current: $17.12
Upside: +203.74%
Maintains: Equal-Weight
Price Target: $36$27
Current: $38.00
Upside: -28.95%
Maintains: Equal-Weight
Price Target: $3$7
Current: $1.65
Upside: +324.24%
Maintains: Outperform
Price Target: $15$27
Current: $13.10
Upside: +106.11%
Maintains: Equal-Weight
Price Target: $30$20
Current: $2.08
Upside: +861.54%
Initiates: Overweight
Price Target: $45
Current: $3.85
Upside: +1,068.83%
Maintains: Overweight
Price Target: $20$10
Current: $0.79
Upside: +1,165.82%
Downgrades: Equal-Weight
Price Target: $3
Current: $4.75
Upside: -36.84%
Upgrades: Equal-Weight
Price Target: $18$30
Current: $5.98
Upside: +401.67%
Maintains: Outperform
Price Target: $300$500
Current: $9.78
Upside: +5,012.47%
Maintains: Outperform
Price Target: $85$80
Current: $33.53
Upside: +138.59%
Maintains: Outperform
Price Target: $12$15
Current: $8.67
Upside: +73.01%